Literature DB >> 17892896

Solvent-free atom transfer radical polymerization for the preparation of poly(poly(ethyleneglycol) monomethacrylate)-grafted Fe3O4 nanoparticles: synthesis, characterization and cellular uptake.

Qu-Li Fan1, Koon-Gee Neoh, En-Tang Kang, Borys Shuter, Shih-Chang Wang.   

Abstract

Poly(poly(ethyleneglycol) monomethacrylate) (P(PEGMA))-grafted magnetic nanoparticles (MNPs) were successfully prepared via a solvent-free atom transfer radical polymerization (ATRP) method. The macroinitiators were immobilized on the surface of 6.4+/-0.8 nm Fe(3)O(4) nanoparticles via effective ligand exchange of oleic acid with 3-chloropropionic acid (CPA), which rendered the nanoparticles soluble in the PEGMA monomer. The so-obtained P(PEGMA)-grafted MNPs have a uniform hydrodynamic particle size of 36.0+/-1.2 nm. The successful grafting of P(PEGMA) on the MNP surface was ascertained from FTIR and XPS analyses. The uptake of the MNPs by macrophage cells is reduced by two-orders of magnitude to <2 pg Fe/cell after surface grafting with P(PEGMA). Furthermore, the morphology and viability of the macrophage cells cultured in a medium containing 0.2 mg/mL of P(PEGMA)-grafted MNPs were found similar to those of cells cultured without nanoparticles, indicating an absence of significant cytotoxicity effects. T(2)-weighted magnetic resonance imaging (MRI) of P(PEGMA)-grafted MNPs showed that the magnetic resonance signal is enhanced significantly with increasing nanoparticle concentration in water. The R(1) and R(2) values per millimole Fe, and R(2)/R(1) value of the P(PEGMA)-grafted MNPs were calculated to be 8.8 mm(-1)s(-1), 140 mm(-1)s(-1), and 16, respectively. These results indicate that the P(PEGMA)-grafted MNPs have great potential for application in MRI of specific biotargets.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892896     DOI: 10.1016/j.biomaterials.2007.08.039

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  8 in total

Review 1.  Nanoparticle-based drug delivery: case studies for cancer and cardiovascular applications.

Authors:  Paul Galvin; Damien Thompson; Katie B Ryan; Anna McCarthy; Anne C Moore; Conor S Burke; Maya Dyson; Brian D Maccraith; Yurii K Gun'ko; Michelle T Byrne; Yuri Volkov; Chris Keely; Enda Keehan; Michael Howe; Conor Duffy; Ronan MacLoughlin
Journal:  Cell Mol Life Sci       Date:  2011-10-21       Impact factor: 9.261

2.  Acid-Sensitive Magnetic Nanoparticles as Potential Drug Depots.

Authors:  Shy Chyi Wuang; Koon Gee Neoh; En-Tang Kang; Deborah E Leckband; Daniel W Pack
Journal:  AIChE J       Date:  2011-06       Impact factor: 3.993

3.  ATRP in the design of functional materials for biomedical applications.

Authors:  Daniel J Siegwart; Jung Kwon Oh; Krzysztof Matyjaszewski
Journal:  Prog Polym Sci       Date:  2011-08-25       Impact factor: 29.190

4.  Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies.

Authors:  Wei Wu; Quanguo He; Changzhong Jiang
Journal:  Nanoscale Res Lett       Date:  2008-10-02       Impact factor: 4.703

5.  Methods for preparing polymer-decorated single exchange-biased magnetic nanoparticles for application in flexible polymer-based films.

Authors:  Laurence Ourry; Delphine Toulemon; Souad Ammar; Fayna Mammeri
Journal:  Beilstein J Nanotechnol       Date:  2017-02-09       Impact factor: 3.649

6.  Stealth properties to improve therapeutic efficacy of drug nanocarriers.

Authors:  Stefano Salmaso; Paolo Caliceti
Journal:  J Drug Deliv       Date:  2013-03-07

Review 7.  Perspective of Fe3O4 Nanoparticles Role in Biomedical Applications.

Authors:  Mohammad Reza Ghazanfari; Mehrdad Kashefi; Seyyedeh Fatemeh Shams; Mahmoud Reza Jaafari
Journal:  Biochem Res Int       Date:  2016-05-12

8.  Facile synthesis of core-shell nanocomposites Au catalysts towards abatement of environmental pollutant Rhodamine B.

Authors:  A Ramesh; P Tamizhdurai; S Gopinath; K Sureshkumar; E Murugan; K Shanthi
Journal:  Heliyon       Date:  2019-01-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.